Showing results (1431-1440 of 1,823) with videos related to

Sort By:
Pageof 183
Transplantation and Cellular Therapy|January 26, 2022
High Proliferating Regulatory T Cells Post-Transplantation Are Associated with Poor Survival in Lymphoma Patients Treated with Autologous Hematopoietic Stem Cell TransplantationNuttavut Sumransub, Qing Cao, Rose Wangen, et al.
Transplantation and Cellular Therapy|July 26, 2022
Untreated Donor-Specific HLA Antibodies Are Associated With Graft Failure and Poor Survival After Haploidentical Transplantation With Post-Transplantation Cyclophosphamide in Pediatric Patients With Nonmalignant DisordersAlberto Cardoso Martins Lima, Carmem Bonfim, Joselito Getz, et al.
Transplantation and Cellular Therapy|July 15, 2022
A Multicenter Phase II, Double-Blind, Placebo-Controlled Trial of Maintenance Ixazomib After Allogeneic Transplantation for High-Risk Multiple Myeloma: Results of the Blood and Marrow Transplant Clinical Trials Network 1302 TrialQaiser Bashir, Taiga Nishihori, Marcelo C Pasquini, et al.
Transplantation and Cellular Therapy|July 25, 2022
Epidemiology of Lower Respiratory Tract Infections and Community-Acquired Respiratory Viruses in Patients with Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation: A Retrospective Cohort StudyDavid J Epstein, Emily C Liang, Husham Sharifi, et al.
Transplantation and Cellular Therapy|July 25, 2022
Chimeric Antigen Receptor T Cell Therapy versus Hematopoietic Stem Cell Transplantation: An Evolving PerspectiveScott R Goldsmith, Armin Ghobadi, John F Dipersio, et al.
Transplantation and Cellular Therapy|April 23, 2022
A Clinically Applicable Prediction Model to Improve T Cell Collection in Chimeric Antigen Receptor T Cell TherapyTomoyasu Jo, Satoshi Yoshihara, Asuka Hada, et al.
Transplantation and Cellular Therapy|February 26, 2022
B Cell Aplasia Is the Most Powerful Predictive Marker for Poor Humoral Response after BNT162b2 mRNA SARS-CoV-2 Vaccination in Recipients of Allogeneic Hematopoietic Stem Cell TransplantationMaxime Jullien, Amandine Le Bourgeois, Marianne Coste-Burel, et al.
Transplantation and Cellular Therapy|September 27, 2021
Good Engraftment but Quality and Donor Concerns for Cryopreserved Hemopoietic Progenitor Cell Products Collected During the COVID-19 PandemicDuncan Purtill, Cheryl Hutchins, Glen Kennedy, et al.
Transplantation and Cellular Therapy|April 12, 2022
Hepatitis B Virus Vaccination after Allogeneic Hematopoietic Cell Transplantation Prevents Post-Transplantation Hepatitis B Virus ReactivationSarah P Hammond, Vincent T Ho, Francisco M Marty
Transplantation and Cellular Therapy|December 5, 2023
Non-Graft-versus-Host Disease Enterocolitis Following Cord Blood Transplantation is Real, with Poorly Understood Pathophysiology, and Requires Distinct Management, with Eventual Resolution without Immune SuppressionClaire Horgan, Stefania Bitetti, Melanie Newbould, et al.
Pageof 183